Tango Therapeutics Inc (TNGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 5,758 | 5,716 | 6,787 | 18,153 | 6,386 |
| Gross Profit | 5,758 | 5,716 | 6,787 | 18,153 | 6,386 |
| Operating Expenses | 31,137 | 27,700 | 26,356 | 22,709 | 18,467 |
| Operating Income | -25,379 | -21,984 | -19,569 | -4,556 | -12,081 |
| Other Income | 171 | 115 | 41 | 42 | 49 |
| Pre-tax Income | -25,208 | -21,869 | -19,528 | -4,514 | -12,032 |
| Income Tax | N/A | 177 | 62 | -21 | 74 |
| Net Income Continuous | -25,208 | -22,046 | -19,590 | -4,493 | -12,106 |
| Net Income | $-25,208 | $-22,046 | $-19,590 | $-4,493 | $-12,106 |
| EPS Basic Total Ops | -0.29 | -0.28 | -0.28 | -0.09 | -0.29 |
| EPS Basic Continuous Ops | -0.29 | -0.27 | -0.28 | -0.09 | -0.29 |
| EPS Diluted Total Ops | -0.29 | -0.28 | -0.28 | -0.09 | -0.29 |
| EPS Diluted Continuous Ops | -0.29 | -0.27 | -0.28 | -0.09 | -0.29 |
| EBITDA(a) | $-25,070 | $-21,728 | $-19,344 | $-4,344 | $-11,877 |